Table 1.
First Authors (Year) | Country | Case (n) | Co ntrol (n) | Sample | Mean Age, Year Case/Control | F/M Case/Control |
---|---|---|---|---|---|---|
Cabrerizo (2017)20 | Spain | OAG (10) | Myopia (10) | AH | 68.8:55.9 | 6/4:6/4 |
Buisset (2019)21 | France | POAG (26) | Cataract (26) | AH | 74.69:74.92 | 12/14:12/14 |
Myer (2020)22 | USA | POAG (23) | Cataract (35) | AH | 73.74:70.71 | 3/20:0/35 |
Pan (2020)23 | China | POAG (16) | Cataract (24) | AH | 72.5:74.2 | 9/16:15/9 |
Burgess (2015)24 | USA | POAG (72) | Healthy (72) | Plasma | 67.8:68.5 | 45/27:41/31 |
Leruez (2018)25 | France | POAG (36) | Cataract (27) | Plasma | 72.00:73.04 | 21/15:12/15 |
Kouassi Nzoughet (2019)26 | France | POAG (34) | Cataract (30) | Plasma | — | — |
Javadiyan (2012)27 | Australia | POAG (211) | Healthy (295) | Serum | 78:76 | 100/111:160/135 |
Umeno (2019)17 | Japan | POAG (198) | Control (119) | Serum | 70.4:70.6 | 106/92:83/36 |
Gong (2020)28 | China | POAG (30) | Healthy (30) | Serum | 54.77:53.80 | 16/14:16/14 |
Rossi (2019)29 | Italy | POAG (16) | Healthy (17) | Tear | 64.63:61.53 | 9/7:10/7 |
Boucard (2007)30 | Netherlands | POAG (7) | Control (12) | Occipital brain region | 73:62 | 1/6:4/8 |
Sidek (2016)31 | USA | Mild POAG (15) Severe POAG (15) | Healthy (15) | ON | 64.9&69.7:53.9 | 9/6&6/9:3/12 |
Rong (2017)32 | China | PACG (38) | Healthy (48) | Serum | 60.45:60.25 | 19/19:24/24 |
Chen (2019)33 | China | PCG (30) | Cataract (20) | AH | — | — |
Myer (2020)34 | USA | PEXG (31) | Cataract (25) | AH | — | — |
Barbosa Breda (2020)35 | Belgium | Glaucoma (54) | Cataract (29) | AH | 71:75 | 38/16:16/13 |
Doganay (2012)18 | USA | Glaucoma (29) | Healthy (13) | LGB & Vitreous body | 65.8:62.8 | 13/16:7/6 |
PACG, primary angle-closure glaucoma; PEXG, pseudoexfoliation glaucoma; PCG, primary congenital glaucoma; ON, optic nerve; LGB, lateral geniculate body.